Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3

Oncogene

Volumn 24, Issue 6, 2005, Pages 980-991

  Kanzawa, Takao ^a,b   Zhang, Li ^a   Xiao, Lianchun ^a   Germano, Isabelle M ^b   Kondo, Yasuko ^a,b   Kondo, Seiji ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic trioxide; Autophagy; BNIP3; Glioma; LC3

Indexed keywords

ARSENIC TRIOXIDE; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN BNIP3L; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BNIP3 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DNA MICROARRAY; GLIOBLASTOMA; HUMAN; HUMAN CELL; LIGHT CHAIN; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; APOPTOSIS; BIOSYNTHESIS; BRAIN TUMOR; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; GLIOMA; PATHOLOGY; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; AUTOPHAGY; BLOTTING, WESTERN; BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 13944256602     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208095     Document Type: Article

References (56)

1. Akao Y, Nakagawa Y and Akiyama K. (1999). FEBS Lett., 455, 59-62.
2. Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, Fairlie DW, Breit SN, Paralkar VM, de Tribolet N, Van Meir EG and Hegi ME. (2002). Oncogene, 21, 4212-4219.
3. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P and Ogier-Denis E. (2001). J. Biol. Chem., 276, 35243-35246.
4. Ayllon V, Martinez AC, Garcia A, Cayla X and Rebollo A. (2000). EMBO J., 19, 2237-2246.
5. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C and Chinnadurai G. (1994). Cell, 79, 341-351.
6. Brandes AA, Basso U and Pasetto LM. (2001). Expert Rev. Anticancer Ther., 1, 357-370.
7. Burton EC and Prados MD. (2000). Curr. Treat. Options Oncol., 1, 459-468.
8. Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, Saxena S, Gietz RD and Greenberg AH. (1997). J. Exp. Med., 186, 1975-1983.
9. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY and Chen Z. (1996). Blood, 88, 1052-1061.
10. Clifford JL, Yang X, Walch E, Wang M and Lippman SM. (2003). Mol. Cancer Ther., 2, 453-459.
11. Cohen I, Castedo M and Kroemer G. (2002). Trends Cell Biol., 12, 293-295.
12. Elmore SP, Qian T, Grissom SF and Lemasters JJ. (2001). FASEB J., 15, 2286-2287.
13. Ferri KF and Kroemer G. (2001). Nat. Cell Biol., 3, E255-E263.
14. Goldstein JC, Waterhouse NJ, Juin P, Evan GI and Green DR. (2000). Nat. Cell Biol., 2, 156-162.
15. Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS and Boise LH. (2001). Blood, 98, 805-813.
16. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K, Yu KT, Jaye M and Ivashchenko Y. (2001). Cell Death Differ., 8, 367-376.
17. Hunter M, Bernard R, Freitas E, Boyer A, Morar B, Martins IJ, Tournev I, Jordanova A, Guergelcheva V, Ishpekova B, Kremensky I, Nicholson G, Schlotter B, Lochmuller H, Voit T, Colomer J, Thomas PK, Levy N and Kalaydjieva L. (2003). Hum. Mutat., 22, 129-235.
18. Imazu T, Shimizu S, Tagami S, Matsushima M, Nakamura Y, Miki T, Okuyama A and Tsujimoto Y. (1999). Oncogene, 18, 4523-4529.
19. Ishitsuka K, Ikeda R, Utsunomiya A, Uozumi K, Hanada S, Suzuki S, Takeuchi S, Takatsuka Y, Takeshita T, Ohno N and Arima T. (2002). Leuk. Lymphoma, 43, 1107-1114.
20. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T. (2000). EMBO J., 19, 5720-5728.
21. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y and Kondo S. (2004). Cell Death Differ., 11, 448-457.
22. Kanzawa T, Kondo Y, Ito H, Kondo S and Germano IM. (2003). Cancer Res., 63, 2103-2108.
23. Kim J and Klionsky DJ. (2000). Annu. Rev. Biochem., 69, 303-342.
24. Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H and Naoe T. (2000). Leukemia, 14, 1743-1750.
25. Kitamuro T, Takahashi K, Nakayama M, Murakami O, Hida W, Shirato K and Shibahara S. (2000). J. Neurochem., 75, 1826-1833.
26. Klionsky DJ and Emr SD. (2000). Science, 290, 1717-1721.
27. Klionsky DJ and Ohsumi Y. (1999). Annu. Rev. Cell Dev. Biol., 15, 1-32.
28. Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A and Barnett GH. (1995). Cancer Res., 55, 6166-6171.
29. Kubasiak LA, Hernandez OM, Bishopric NH and Webster KA. (2002). Proc. Natl. Acad. Sci. USA, 99, 12825-12830.
30. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H and Levine B. (1999). Nature, 402, 672-676.
31. Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP, Kornblum HI, Nelson SF and Bronstein JM. (2000). Cancer Res., 60, 1353-1360.
32. Lockshin RA and Zakeri Z. (2001). Nat. Rev. Mol. Cell Biol., 2, 545-550.
33. Lockshin RA and Zakeri Z. (2002). Curr. Opin. Cell Biol., 14, 727-733.
34. Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y and Kakizuka A. (2002). Cancer Res., 61, 5432-5440.
35. Martinou JC and Green DR. (2001). Nat. Rev. Mol. Cell Biol., 2, 63-67.
36. Mentlein R and Held-Feindt J. (2002). J. Neurochem., 83, 747-753.
37. Miller Jr WH. (2002). Oncologist, 7, 14-19.
38. Miller Jr WH, Schipper HM, Lee JS, Singer J and Waxman S. (2002). Cancer Res., 62, 3893-3903.
39. Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y and Yoshimori T. (2001). J. Cell Biol., 152, 657-668.
40. Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, Li JM, Zeng XY, Yang RR, Yuan MM, Ren MY, Gu FY, Cao Q, Gu BW, Su XY, Chen GQ, Xiong SM, Zhang T, Waxman S, Wang ZY, Chen SJ, Hu J, Shen ZX and Chen SJ. (1999). Blood, 94, 3315-3324.
41. Puthalakath H and Strasser A. (2002). Cell Death Differ., 9, 505-512.
42. Reed JC. (1999). J. Clin. Oncol., 17, 2941-2953.
43. Schwartz LM, Smith SW, Jones ME and Osborne BA. (1993). Proc. Natl. Acad. Sci. USA, 90, 980-984.
44. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z and Wang ZY. (1997). Blood, 89, 3354-3360.
45. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP and Warrell Jr RP. (1998). N. Engl. J. Med., 339, 1341-1348.
46. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH and Harris AL. (2001). Cancer Res., 61, 6669-6673.
47. Sullivan PG, Thompson MB and Scheff SW. (1999). Exp. Neurol., 160, 226-234.
48. Tenan M, Fulci G, Albertoni M, Diserens AC, Hamou MF, El Atifi-Borel M, Feige JJ, Pepper MS and Van Meir EG. (2000). J. Exp. Med., 191, 1789-1798.
49. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H and Gundersen G. (1997). Br. J. Cancer, 75, 1744-1752.
50. Unoki M and Nakamura Y. (2003). Oncogene, 22, 2172-2185.
51. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH. (2000). Mol. Cell. Biol., 20, 5454-5468.
52. Yao KC, Komata T, Kondo Y, Kondo S and Germano IM. (2003). J. Neurosurg., 98, 378-384.
53. Yasuda M, Theodorakis P, Subramanian T and Chinnadurai G. (1998). J. Biol. Chem., 273, 12415-12421.
54. Zhang L, Miles MF and Aldape KD. (2003). Nat. Biotechnol., 21, 818-821.
55. Zheng XH, Watts GS, Vaught S and Gandolfi AJ. (2003). Toxicology, 187, 39-48.
56. Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y, Tang W, Shi GY, Sun YP, Dai J, Wang ZY, Chen SJ, Zhang TD, Waxman S, Chen Z and Chen GQ. (1999). J. Natl. Cancer Inst., 91, 772-778.